Malignant Disease and Immunosuppression
BNF Chapter 08
Items (National)
4.5M
NHS Cost
£162.6M
Substances
71
Sections
3
The Malignant Disease and Immunosuppression chapter of the BNF contains 71 chemical substances prescribed across England, totalling 4,534,001 items at a cost of £162,586,659 to the NHS.
Sections
| Section | Items | Cost | Substances |
|---|---|---|---|
| Cytotoxic drugs | 191.2K | £5.5M | 31 |
| Drugs affecting the immune response | 1.0M | £22.3M | 16 |
| Sex hormones and hormone antagonists in malignant disease | 3.3M | £134.8M | 24 |
Top Drugs in Malignant Disease and Immunosuppression
| Drug | Items | Cost |
|---|---|---|
| Letrozole | 1.2M | £4.1M |
| Azathioprine | 686.7K | £1.5M |
| Tamoxifen citrate | 517.0K | £2.5M |
| Anastrozole | 515.4K | £996.6K |
| Leuprorelin acetate | 256.7K | £47.5M |
| Goserelin acetate | 248.4K | £37.9M |
| Mycophenolate mofetil | 217.4K | £6.1M |
| Bicalutamide | 177.0K | £391.3K |
| Exemestane | 174.7K | £1.4M |
| Hydroxycarbamide | 89.1K | £959.7K |
| Triptorelin | 85.0K | £16.9M |
| Tacrolimus | 80.9K | £10.7M |
| Mercaptopurine | 54.1K | £1.2M |
| Methotrexate | 40.7K | £2.6M |
| Ciclosporin | 33.3K | £2.6M |
| Degarelix | 32.3K | £3.9M |
| Triptorelin embonate | 26.5K | £10.6M |
| Cyproterone acetate | 26.4K | £1.1M |
| Triptorelin acetate | 21.6K | £1.5M |
| Medroxyprogesterone acetate | 15.2K | £585.6K |